Forbes: CVS Caremark, the drug retailer and pharmacy benefit management firm, announced a new agreement with Aetna to help constrain drug costs. "The deal encompasses approximately $9.5 billion in annual drug spending relating to approximately 9.7 million lives. CVS expects significant long-term financial benefits from this strategic relationship" (7/28). The Street: The 12-year deal helped mask a weak performance in second quarter earnings for CVS. "CVS Caremark ... missed second-quarter expectations, lowering its outlook. But a massive deal with health insurer Aetna...
More...
More...